InvestorsHub Logo
Followers 51
Posts 9120
Boards Moderated 1
Alias Born 10/25/2007

Re: None

Thursday, 11/10/2022 11:46:38 PM

Thursday, November 10, 2022 11:46:38 PM

Post# of 13509
Harbour BioMed Enters into a License and Collaboration Agreement with Moderna

he strategic collaboration will focus on discovering and developing nucleic acid-based immunotherapies for select oncology targets using the Company's proprietary heavy chain only antibody discovery platform (HCAb).

https://www.prnewswire.com/news-releases/harbour-biomed-enters-into-a-license-and-collaboration-agreement-with-moderna-301675149.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News